Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021,Morbidity and Mortality Weekly Report

当前位置： X-MOL 学术 › Morb. Mortal. Wkly. Rep. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021
Morbidity and Mortality Weekly Report ( IF 25.4 ) Pub Date : 2022-06-16 , DOI: 10.15585/mmwr.mm7124a2
Javier Martin , Cara C. Burns , Jaume Jorba , Lester M. Shulman , Andrew Macadam , Dimitra Klapsa , Manasi Majumdar , James Bullows , Ann Frolov , Ryan Mate , Erika Bujaki , Christina J. Castro , Kelley Bullard , John Konz , Kaija Hawes , Jillian Gauld , Isobel M. Blake , Laina D. Mercer , Feyrouz Kurji , Arie Voorman , Ousmane M. Diop , M. Steven Oberste , John Modlin , Grace Macklin , Martin Eisenhawer , Ananda S. Bandyopadhyay , Simona Zipursky

中文翻译：